- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Recombinant human acid alpha-glucosidase conjugated with man
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Recombinant human acid alpha-glucosidase conjugated with mannose-6-phosphate analogues
| EU orphan designation number: | EU/3/16/1726
|
| Active ingredient: | Recombinant human acid alpha-glucosidase conjugated with mannose-6-phosphate analogues |
| Indication: | Treatment of glycogen storage disease type II (Pompe’s disease) |
| Sponsor: | NanoMedSyn
15 Avenue Charles Flahault, Faculté de Pharmacie, Bât E 2ème étage, 34093 Montpellier cedex 5, France |
Public summary of scientific opinion
European Commission procedures |
CONTACT
EU links
Directorate General Health & Consumers